Albion Finch Medical Centre
- Physician-led: three physicians on site take part in research
- Every study is reviewed by a research ethics board before it opens
- Run under Health Canada regulations and ICH Good Clinical Practice
- What you submit goes only to this site’s research team
About this research site
Dr. Anil Gupta is an energetic physician and researcher, leading studies in a number of different therapeutic areas. In addition to a busy clinic practice and his research work, Dr. Gupta has served as an Organizing Member for Toronto Public Health's Influenza Vaccination Program and is a Lecturer in the Faculty of Medicine at University of Toronto. His clinic is open 7 days a week.
The people who would look after you
The investigators below are responsible for the studies run at this site, supported by the research team who coordinate your visits. These are the people you would meet.

Has led clinical trials at this site since 2006 and is a Lecturer in the Faculty of Medicine at the University of Toronto. CPSO registration #65242.

Has cared for patients at Albion Finch since 2004 and has been involved in clinical research since 2007. Holds a PhD in biochemistry alongside his medical degree.

A family physician across the Toronto and Etobicoke areas for more than twenty years, and involved in clinical research since 2008.



- PatriciaStudy coordinator
- PranshuStudy coordinator
Therapeutic experience
Areas of medicine studied at this site, based on data from 2006 to 2026.
What this site has done
How research started here
- 2006Clinical research begins at the clinicDr. Gupta became a principal investigator in 2006. The site has since run studies across many areas of medicine, including research that contributed to the approval of new medicines in Canada.
- Today3 studies enrolling in TorontoAcross 13 areas of medicine.
Research here becomes medicine everywhere
Clinical studies are funded by the companies developing the treatment being tested. The companies below have sponsored research at this site, and many of them have gone on to bring new medicines to Canadians. A name here does not mean one of their studies is enrolling right now, and it is not an endorsement of any product.
Avillion, Biota, CombinatoRx, EMD Serono, Flexion, Intarcia, Ixaltis, Janssen, Labopharm, MediVector, Omthera, Pliant Therapeutics, Ralexar Therapeutics, Inc, resTORbio, Trial Management Group Inc.
- Diabetes
- Forxiga
- Jardiance
- Lantus / Toujeo
- Ozempic / Wegovy / Rybelsus
- Trulicity
- Victoza
- Awiqli
- Invokana
- Onglyza
- Soliqua
- Trajenta
- Tresiba
- Lungs and breathing
- Advair
- Dupixent
- Symbicort
- Trelegy
- Ventolin
- Acarizax
- Anoro
- Atectura
- Breo
- Breztri
- Cinqair
- Ebglyss
- Enerzair
- Fasenra
- Grastek
- Ragwitek
- Vaccines and infections
- Arexvy
- Paxlovid
- Spikevax
- Tamiflu
- Abrysvo
- Bexsero
- Menveo
- Heart and circulation
- Brilinta
- Ilaris
- Cholesterol and lipids
- Crestor
- Repatha
- Nilemdo
- Praluent
- Pain, bones and joints
- Prolia
- Pentosan polysulfate
- Triamcinolone acetonide
- Weight and metabolic health
- Mounjaro / Zepbound
- General and preventive health
- Varenicline
- Bladder and urinary
- DDAVP
A medicine is listed because it was part of at least one study at this site. This is not a recommendation: only your own doctor can say whether a medicine is right for you.
Studies you could join at this site
3 studies are recruiting here now.
Getting here, and what a first visit looks like
Friday: 9:00 am - 1:00 pm
Saturday: 9:00 am - 1:00 pm
Sunday: 9:00 am - 3:00 pm
- 1A phone call firstA coordinator calls to go through your health history and answer your questions. Nothing is booked until you want it to be.
- 2Informed consentThe team walks through the study in plain language, including what is being tested and the known risks.
- 3Screening checksSimple tests confirm whether the study is a fit. Being screened does not commit you to taking part.
- 4Your decisionYou choose whether to continue, and you can stop at any point without affecting your regular care.
Inside the clinic
5 photos, scroll for more







